Link to this page
Human Health Exposure Analysis Resource
Last uploaded:
July 19, 2024
Jump to:
| Preferred Name | maple syrup urine disease | |
| Synonyms |
dihydrolipoamide dehydrogenase deficiency Ketoacidaemia branched chain ketoaciduria |
|
| Definitions |
An organic acidemia that is caused by a deficiency of decarboxylase leading to high concentrations of valine, leucine, isoleucine, and alloisoleucine in the blood, urine, and cerebrospinal fluid and characterized by an odor of maple syrup to the urine, vomiting, hypertonicity, severe mental retardation, seizures, and eventually death unless the condition is treated with dietary measures. Xref MGI. OMIM mapping confirmed by DO. [SN]. |
|
| ID |
http://purl.obolibrary.org/obo/DOID_9269 |
|
| comment |
Xref MGI.
OMIM mapping confirmed by DO. [SN].
|
|
| alternative label |
dihydrolipoamide dehydrogenase deficiency Ketoacidaemia branched chain ketoaciduria
|
|
| database_cross_reference |
UMLS_CUI:C0024776 MESH:D008375 ICD10CM:E71.0 SNOMEDCT_US_2023_03_01:27718001 GARD:3228 MIM:246900 MIM:248600 MIM:615135 NCI:C34806 ORDO:511
|
|
| definition |
An organic acidemia that is caused by a deficiency of decarboxylase leading to high concentrations of valine, leucine, isoleucine, and alloisoleucine in the blood, urine, and cerebrospinal fluid and characterized by an odor of maple syrup to the urine, vomiting, hypertonicity, severe mental retardation, seizures, and eventually death unless the condition is treated with dietary measures. Xref MGI.
OMIM mapping confirmed by DO. [SN].
|
|
| has exact synonym |
Ketoacidaemia branched chain ketoaciduria
|
|
| has symptom | ||
| has_obo_namespace |
disease_ontology
|
|
| has_related_synonym |
dihydrolipoamide dehydrogenase deficiency
|
|
| id |
DOID:9269
|
|
| in_subset | ||
| label |
maple syrup urine disease
|
|
| notation |
DOID:9269
|
|
| note |
An organic acidemia that is caused by a deficiency of decarboxylase leading to high concentrations of valine, leucine, isoleucine, and alloisoleucine in the blood, urine, and cerebrospinal fluid and characterized by an odor of maple syrup to the urine, vomiting, hypertonicity, severe mental retardation, seizures, and eventually death unless the condition is treated with dietary measures. Xref MGI.
OMIM mapping confirmed by DO. [SN].
|
|
| preferred label |
maple syrup urine disease
|
|
| prefLabel |
maple syrup urine disease
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping